BioCentury
ARTICLE | Financial News

Acadia raises $100 million in follow-on

May 16, 2013 12:56 AM UTC

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) raised $100 million through the sale of 8 million shares at $12.50 in a follow-on underwritten by Jefferies; Cowen; JMP Securities; Needham; Ladenburg Thalmann; Roth Capital Partners; and SunTrust Robinson Humphrey. Acadia proposed the offering late Tuesday, when its stock price was $12.95. Acadia was up $0.10 to $13.05 on Wednesday. ...